NYMC > Faculty > Directory > By Name > Dattwyler, Raymond

Raymond Dattwyler, M.D.

Professor of Microbiology and Immunology

Dr. Dattwyler’s research aims to develop new diagnostic tests for infectious diseases, including Lyme disease. These new tests will lead to earlier diagnosis of Lyme disease and enable prompt treatment that may prevent the development of serious symptoms, such as arthritis and neuroborreliosis.

Biography:

The Division of Clinical Immunology, Allergy and Rheumatology addresses the full range of immunologically mediated disease. It consists of four full-time physicians, two clinical immunologists/allergists and two rheumatologists who care for patients with an array of immunologic disorders: allergic diseases, asthma, allergic rhinitis, immunodeficiency and food allergy. Rheumatologic disorders comprise rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, Lyme arthritis and a full range of other less common or more difficult to diagnose musculoskeletal and connective tissue diseases. Members are involved in direct patient care, training of medical students, residents, fellows and practicing physicians, and research aimed at improving the health of people in general.

Dr. Dattwyler’s research aims to develop new diagnostic tests for infectious diseases, including Lyme disease. These new tests will lead to earlier diagnosis of Lyme disease and enable prompt treatment that may prevent the development of serious symptoms, such as arthritis and neuroborreliosis.

Research, both clinical and translational, bridges the gap between basic science research and clinical medicine. With funding from the NIH, Dr. Dattwyler’s group is working to develop new diagnostic tests for a number of infectious diseases, including Lyme disease. The new Lyme tests are designed to fill the gaps that exist in testing today, particularly for the early diagnosis of Lyme disease.

A new oral vaccine technology in development would have an array of potential uses, from protection against infectious diseases to treatment for food allergy. The CDC is sponsoring field trials to determine if an oral bait vaccine against Lyme disease can help control its spread in wildlife and the ticks that feed on them, thereby reducing the tick population that spreads Lyme bacteria to humans. The oral vaccine technique is also under study as a possible means of protection against other bacterial infectious diseases

Industry Expertise:

  • Education/Learning
  • Health and Wellness
  • Health Care - Providers
  • Health Care - Services
  • Medical Devices
  • Medical/Dental Practice
  • Research
  • Biotechnology

Areas of Expertise:

Molecular Biology, Cell Biology, Science, Clinical Immunology, Allergy and Rheumatology, Lyme Disease Research

Education:

Fellowship, Immunology: Mayo Clinic
Internship, Internal Medicine: University of Wisconsin Hospital
M.D., Medicine: S.U.N.Y Health Science Center

Affiliations:

  • Clinical & Laboratory Immunology
  • American Board of Allergy & Immunology
  • American Board of Internal Medicine

Media Appearances:

Search for "Raymond Dattwyler" on the top of the NYMC in the News page.

Search PubMed for all available publications of Raymond Dattwyler, M.D.